Improvements in Submental Contour up to 3 Years After ATX-101: Efficacy and Safety Follow-Up of the Phase 3 REFINE Trials

BACKGROUND: ATX-101 (deoxycholic acid) significantly reduced submental fat (SMF) severity in two 24-week Phase 3 studies (REFINE-1 and REFINE-2). OBJECTIVES: The aim of this study was to evaluate the durability of effect and long-term safety of ATX-101. METHODS: REFINE study patients who maintained...

Descripción completa

Detalles Bibliográficos
Autores principales: Humphrey, Shannon, Cohen, Joel L, Bhatia, Ashish C, Green, Lawrence J, Green, Jeremy B, Bowen, Beta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Body Contouring
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520020/
https://www.ncbi.nlm.nih.gov/pubmed/33617632
http://dx.doi.org/10.1093/asj/sjab100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520020/
https://www.ncbi.nlm.nih.gov/pubmed/33617632
http://dx.doi.org/10.1093/asj/sjab100

Ejemplares similares